Funding Rounds
NanoCor Therapeutics

NanoCor Therapeutics Series B round, September 2007

NanoCor Therapeutics

A biotechnology company developing intracellular genetic protein therapy to treat chronic heart failure

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series B

Raised Amount: $6.30M

Raised Date: 2007-09-01